These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21390074)

  • 1. The establishment of a methadone treatment clinic for women in Tehran, Iran.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Mokri A
    J Public Health Policy; 2011 May; 32(2):219-30. PubMed ID: 21390074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: reaching women drug users with methadone treatment and other HIV prevention services in Tehran.
    Claeson M
    J Public Health Policy; 2011 May; 32(2):231-3. PubMed ID: 21368851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Iranian women seeking drug treatment.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
    J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's health issues require unique approach.
    Phillips M
    Radiol Manage; 2004; 26(5):45-7. PubMed ID: 15543704
    [No Abstract]   [Full Text] [Related]  

  • 6. Serving women who use drugs in Delhi, India: challenges and achievements.
    Sarin E; Selhore E
    Int J Drug Policy; 2008 Apr; 19(2):176-8. PubMed ID: 18313911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of coordinated services for drug-abusing women who are victims of intimate partner violence.
    Bennett L; O'Brien P
    Violence Against Women; 2007 Apr; 13(4):395-411. PubMed ID: 17420517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis.
    Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM
    J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
    Rácz J; Melles K; Márványkövi F; Vadász V
    Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's health: marketing challenges for the 21st century. The future of women's health care reflects demographic, social, and economic trends. MHS staff.
    Mark Health Serv; 2000; 20(3):4-11. PubMed ID: 11185874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women and substance use disorders.
    Walton-Moss BJ; Becker KL
    Lippincotts Prim Care Pract; 2000; 4(3):290-301. PubMed ID: 11271126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
    Crockett B; Gifford SM
    Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A women-only clinic for HIV, genitourinary medicine and substance misuse.
    McCarthy GA; Cockell AP; Kell PD; Beevor AS; Boag FC
    Genitourin Med; 1992 Dec; 68(6):386-9. PubMed ID: 1487260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, STD and hepatitis prevention among women in methadone maintenance: a qualitative and quantitative needs assessment.
    Morrow K; Costello T
    AIDS Care; 2004 May; 16(4):426-33. PubMed ID: 15203411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of case management on rural women's quality of life and substance use.
    Passey M; Sheldrake M; Leitch K; Gilmore V
    Rural Remote Health; 2007; 7(3):710. PubMed ID: 17683243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.